112 related articles for article (PubMed ID: 31680850)
1. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease.
Karami A; Eriksdotter M; Kadir A; Almkvist O; Nordberg A; Darreh-Shori T
Front Mol Neurosci; 2019; 12():239. PubMed ID: 31680850
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.
Smith GS; Kramer E; Ma Y; Hermann CR; Dhawan V; Chaly T; Eidelberg D
Brain; 2009 Feb; 132(Pt 2):392-401. PubMed ID: 19153152
[TBL] [Abstract][Full Text] [Related]
3. Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine.
Crews FT; Fisher R; Deason C; Vetreno RP
Front Behav Neurosci; 2021; 15():652494. PubMed ID: 33716687
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic Crisis with Normal Serum Cholinesterase Levels due to Excessive Galantamine Ingestion: A Case Report.
Suzuki A; Mayahara T; Katayama T; Arai H; Matsuura K; Nagata K; Maruo E
JMA J; 2024 Apr; 7(2):292-294. PubMed ID: 38721068
[TBL] [Abstract][Full Text] [Related]
5. New acetylcholinesterase inhibitors for Alzheimer's disease.
Mehta M; Adem A; Sabbagh M
Int J Alzheimers Dis; 2012; 2012():728983. PubMed ID: 22216416
[TBL] [Abstract][Full Text] [Related]
6. Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease.
Khan MB; Palaka BK; Sapam TD; Subbarao N; Ampasala DR
Bioinformation; 2018; 14(8):414-428. PubMed ID: 30310249
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of korean white, red, and black ginseng extract on cholinesterase inhibitory activity and cholinergic function.
Lee MR; Yun BS; In OH; Sung CK
J Ginseng Res; 2011 Nov; 35(4):421-8. PubMed ID: 23717087
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease.
Gok M; Madrer N; Zorbaz T; Bennett ER; Greenberg D; Bennett DA; Soreq H
Front Mol Neurosci; 2022; 15():941467. PubMed ID: 36117917
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic Dysfunction in Patients with Psoriatic Arthritis and Immunocompetent Controls: A Cross-Sectional Study.
Nochomovitz H; Berliner S; Elkayam O; Zeltser D; Shapira I; Rogowski O; Gertel S; Shenhar-Tsarfaty S; Furer V
Isr Med Assoc J; 2023 Aug; 25(8):553-558. PubMed ID: 37574894
[TBL] [Abstract][Full Text] [Related]
10. Natural AChE Inhibitors from Plants and their Contribution to Alzheimer's Disease Therapy.
Murray AP; Faraoni MB; Castro MJ; Alza NP; Cavallaro V
Curr Neuropharmacol; 2013 Jul; 11(4):388-413. PubMed ID: 24381530
[TBL] [Abstract][Full Text] [Related]
11. The cholinergic pathway transmits signals of neuropeptide F to regulate feeding of Ostrinia furnacalis larvae.
Jiang X; Shi J; Yang H; Zhao Z
Pest Manag Sci; 2023 Oct; 79(10):3593-3601. PubMed ID: 37183359
[TBL] [Abstract][Full Text] [Related]
12. Presence of key cholinergic enzymes in human spermatozoa and seminal fluid†.
Thakur B; Hasooni LP; Gera R; Mitra S; Björndahl L; Darreh-Shori T
Biol Reprod; 2024 Jan; 110(1):63-77. PubMed ID: 37741056
[TBL] [Abstract][Full Text] [Related]
13. Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer's Disease.
Campos-Peña V; Pichardo-Rojas P; Sánchez-Barbosa T; Ortíz-Islas E; Rodríguez-Pérez CE; Montes P; Ramos-Palacios G; Silva-Adaya D; Valencia-Quintana R; Cerna-Cortes JF; Toral-Rios D
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292947
[TBL] [Abstract][Full Text] [Related]
14. Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease.
Dwomoh L; Tejeda GS; Tobin AB
Neuronal Signal; 2022 Apr; 6(1):NS20210004. PubMed ID: 35571495
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of Myrtenal in an Experimental Model of Dementia Induced in Rats.
Dragomanova S; Pavlov S; Marinova D; Hodzev Y; Petralia MC; Fagone P; Nicoletti F; Lazarova M; Tzvetanova E; Alexandrova A; Kalfin R; Tancheva L
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204256
[TBL] [Abstract][Full Text] [Related]
16. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
Moss DE; Perez RG
Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
[TBL] [Abstract][Full Text] [Related]
17. CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment.
Karami A; Darreh-Shori T; Schultzberg M; Eriksdotter M
Front Aging Neurosci; 2021; 13():704583. PubMed ID: 34512307
[TBL] [Abstract][Full Text] [Related]
18. Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers.
Mitra S; Turconi G; Darreh-Shori T; Mätlik K; Aquilino M; Eriksdotter M; Andressoo JO
Front Aging Neurosci; 2021; 13():714186. PubMed ID: 34475820
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
